Contribution of trifluoperazine/lipid ratio and drug ionization to hemolysis

Biochimica et Biophysica Acta - Biomembranes

Volumn 1373, Issue 2, 1998, Pages 332-340

  Malheiros, Sônia Valéria Pinheiro ^a   De Paula, Eneida ^a   Meirelles, Nilce Correa ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Erythrocyte; Hemolysis; Membrane solubilization; pK shift; Trifluoperazine

Indexed keywords

LIPOSOME; MEMBRANE LIPID; NEUROLEPTIC AGENT; OCTANOL; PHOSPHATIDYLCHOLINE; TRIFLUOPERAZINE; WATER;

ANIMAL CELL; ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG STRUCTURE; ERYTHROCYTE; ERYTHROCYTE GHOST; HEMOLYSIS; IONIZATION; LIPID COMPOSITION; MICROSOME; MOUSE; NONHUMAN; PARTITION COEFFICIENT; PH; PRIORITY JOURNAL; SOLUBILIZATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CELL MEMBRANE; ERYTHROCYTES; HEMOLYSIS; HYDROGEN-ION CONCENTRATION; HYPOTONIC SOLUTIONS; LIPID METABOLISM; MICE; MICROSOMES, LIVER; MOLECULAR STRUCTURE; PHOSPHATIDYLCHOLINES; SURFACE PROPERTIES; TRIFLUOPERAZINE; WATER;

EID: 0032475507     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(98)00090-X     Document Type: Article

References (44)

1. [1] P.P. Kelder, N.J. de Mol, M.J.E. Fischer, L.H.M. Janssen, Biochim. Biophys. Acta 1025 (1994) 230-238.
2. [2] R.S. Pereira, A.F.P. Bertocci, A.E. Vercesi, Biochem. Pharmacol. 41 (1992) 1-7.
3. [3] P. Seeman, Biochem. Pharmacol. 15 (1966) 1753-1766.
4. [4] M.R. Lieber, Y. Lange, R.S. Weinstein, T.L. Stick, J. Biol. Chem. 259 (1984) 9225-9234.
5. [5] B. Deuticke, Biochim. Biophys. Acta 163 (1968) 494-500.
6. [6] M.P. Sheetz, S.J. Singer, Proc. Natl. Acad. Sci. USA 71 (1974) 4457-5561.
7. [7] H. Aki, M. Yamamoto, Biochem. Pharmacol. 41 (1991) 133-138.
8. [8] T. Suda, D. Shimizu, N. Maeda, T. Shiga, Biochem. Pharmacol. 30 (1981) 2057-2064.
9. [9] A.C. Ruggiero, Ph.D thesis, Departamento de Bioquímica, Instituto de Biologia, UNICAMP, 1994.
10. [10] T. Yamaguchi, S. Watanabe, E. Kimoto, Biochim. Biophys. Acta 820 (1985) 157-164.
11. [11] M. Minetti, A.M.N. Di Stasi, Biochemistry 26 (1987) 8133-8137.
12. [12] J. Rosso, A. Zachowski, P.F. Devaux, Biochim. Biophys. Acta 942 (1988) 271-279.
13. [13] A. Spinedi, L. Pacini, C. Limatola, P. Luly, R.N. Farias, Biochem. Pharmacol. 44 (1992) 1511-1514.
14. [14] N.C. Meirelles, S.V.P. Malheiros, A.C. Ruggiero, I.A. Degterev, Eur. J. Drug Met. Pharmacokinet. 19 (1994) 349-357.
15. [15] J.T. Dodge, C. Mitchell, D.J. Hanahan, Arch. Biochem. Biophys. 100 (1963) 131-139.
16. [16] O.H. Lowry, N.J. Rosebrough, S. Farrah, R.J. Randall, J. Biol. Chem. 193 (1951) 265-275.
17. [17] G. Rouser, S. Fleicher, A. Yamamoto, Lipids 5 (1970) 494-496.
18. [18] A.C. Moffat, in: Clarke's Isolation and Identification of drugs, 2nd edn., Pharmac. Press, London, 1986, p. 1044.
19. [19] Y. Katz, J.M. Diamond, J. Membr. Biol. 17 (1974) 69-86.
20. [20] N.P. Franks, W.R. Lieb, Nature 292 (1981) 248-251.
21. [21] E. Lissi, M.L. Bianconi, A.T. AmaraL, E. de Paula, L.E.B. Blanch, S. Schreier, Biochim. Biophys. Acta 1021 (1990) 46-50.
22. [22] SAS Institute, S.A.S. Users Guide: Statistics, 6th edn., Cary, North Carolina, 1987.
23. [23] D. Lichtenberg, Biochim. Biophys. Acta 821 (1985) 470-478.
24. [24] M.A. Partearroyo, M.A. Urbaneja, F.M. Goñi, FEBS Lett. 302 (1992) 138-140.
25. [25] M.A. Requero, F.M. Goñi, A. Alonso, Biochemistry 34 (1995) 10400-10405.
26. [26] D. Lichtenberg, in: M. Shinitzki (Ed.), Biomembranes. Physical Aspects, Weinheim, 1993, pp. 63-95.
27. [27] M.L. Bianconi, S. Schreier, J. Phys. Chem. 95 (1991) 2483-2487.
28. [28] E. de Paula, S. Schreier, Braz. J. Med. Biol. Res. 29 (1996) 877-894.
29. [29] P.J. Marroum, S.H. Curry, J. Pharm. Pharmacol. 45 (1993) 39-42.
30. [30] S. Roth, P. Seeman, Biochim. Biophys. Acta 255 (1972) 207-219.
31. [31] K. Korten, K.W. Miller, Can. J. Physiol. Pharmacol. 57 (1979) 325-328.
32. [32] F.A.P.C. Gobas, J.M. Lahittete, G. Garofalo, W.Y. Shiu, D. Mackay, J. Pharm. Sci. 77 (1988) 265-272.
33. [33] L.R. DeYoung, K.A. Dill, Biochemistry 27 (1988) 5281-5289.
34. [34] H.J. Hird, E.J.T. Mclean, H.N. Munro, Biochim. Biophys. Acta 87 (1964) 219-231.
35. [35] R.C. Warren, Physics and Architecture of Cell Membranes, Adam-Hilger, Bristol, 1987, pp. 1-26.
36. [36] M.R. Vist, J.H. Davis, Biochemistry 29 (1990) 451-464.
37. [37] H.P. Duwe, E. Sackmann, Phys. Acta 163 (1990) 410-428.
38. [38] T. Ogiso, M. Iwaki, M. Kimori, C. Tsukawaki, Chem. Pharm. Bull. 34 (1986) 4301-4307.
39. [39] D. Attwood, A.T. Florence, in: Surfactant Systems, Their Chemistry, Pharmacy and Biology, 2nd. edn, Chapman and Hall, New York, 1983, pp. 124-185.
40. [40] M.A. Requero, F.M. Goñi, A. Alonso, J. Colloid Interface Sci. 161 (1993) 343-346.
41. [41] E.A. Dennis, Arch. Biochem. Biophys. 165 (1974) 764-773.
42. [42] S. Schreier, W.A. Frezzatti Jr., P.S. Araujo, H. Chaimovich, I.M. Cuccovia, Biochim. Biophys. Acta 769 (1984) 231-237.
43. [43] A.G. Lee, S. Schreier, in: G. Gregoriades (Ed.), Liposome Technology, Vol. II, Entrapment of Drugs and Other Materials, CRC Press, Boca Raton, FL, 1993, pp. 1-25.
44. [44] Y. Kanaho, T. Sato, T. Fujii, Mol. Pharmacol. 20 (1981) 704-708.